BMO Capital analyst Michael Markidis lowered the firm’s price target on NorthWest Healthcare (NWHUF) to C$5.25 from C$5.50 and keeps a Market Perform rating on the shares.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.